How to Buy Dr Reddys Laboratories Stock
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories is a pharmaceutical company located in India, which is part of the Healthcare sector, and is traded under the ticker RDY on the NYSE exchange.
Dr Reddys Laboratories stock last closed at $13.92, down 0.14% from the previous day, and has decreased 5.27% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.53 percentage points. Dr Reddys Laboratories stock is currently +13.54% from its 52-week low of $12.26, and -17.59% from its 52-week high of $16.89.
At the moment, there are 834.09M RDY shares outstanding. The market value of RDY is $11.61B. In the last 24 hours, 1.25M RDY shares were traded.
How to Buy Dr Reddys Laboratories Stock
Not sure how to invest in Dr Reddys Laboratories stock? Here's how.
- Choose where to buy Dr Reddys Laboratories stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Dr Reddys Laboratories stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Analyze Dr Reddys Laboratories stock: The Dr Reddys Laboratories ticker symbol is RDY. Is Dr Reddys Laboratories stock a good investment? Should you buy shares of RDY? How do RDY's underlying business fundamentals look? Do top analysts think Dr Reddys Laboratories is a good buy? Why has RDY's stock price moved recently? (Hint: Our stock market research website can help you figure out if RDY is a good stock to buy).
- Make your RDY purchase: Decide if you will purchase RDY shares at the current market price or use a limit order to buy RDY stock at a particular price.
- Track your investment in RDY: Create a watchlist to watch your investment in Dr Reddys Laboratories shares.
Step 1: Choose where to buy Dr Reddys Laboratories stock
You will need an online brokerage account to access the NYSE market and buy RDY shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in RDY stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on stock market app, you need to deposit funds:
Check out the tutorial below for more details transferring money into your brokerage account.
Step 4: Analyze Dr Reddys Laboratories stock
After you have figured out the best place to buy Dr Reddys Laboratories stock, it's absolutely critical to research their stock before you invest, so you truly comprehend the risk and opportunity.
Dr Reddys Laboratories Numbers
Fundamentals of RDY
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on RDY's stock page.
How is RDY stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RDY's intrinsic value.
Using relative valuations ratios:
- RDY could be undervalued based on its P/E ratio of 17.33x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 21.23x
- RDY could be overvalued based on its P/B ratio of 3.45x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can do additional valuation research on RDY's stock here.
A quick look at RDY Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the RDY balance sheet.
- There are more short-term assets than short-term liabilities on the RDY balance sheet.
- RDY profit margin has gone up from 18.3% to 19.9% in the past year.
- RDY has a low debt to equity ratio of 0.38.
- Total RDY debt is lower than 5 years ago, relative to shareholder equity.
- RDY earnings of $883.11M is not sufficient to cover its interest payments.
- RDY's operating cash flow of $545.28M allows it to safely service it's debt of $240.28M.
You can dig deeper into what analysts are forecasting on the Dr Reddys Laboratories stock forecast page.
RDY Technical Indicators
RDY Revenue
Last year, RDY earnings were $668.31M. In the past 5 year, RDY's earnings have gone up by 19.68% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 5.89%.
Last year, RDY revenue was $3.35B. Over the last 5 year, RDY's revenue has gone up by 8.54% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.88%.
Dig into RDY's earnings and revenue performance here.
What are RDY insiders up to?
In the past year, insiders at RDY have not bought or sold any shares.
Dig into more about who owns RDY shares here.
Can I rely on RDY as an income stream?
Dr Reddys Laboratories pays a dividend of 0.69%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 3.51%. If you owned $1,000 worth of RDY stock, you would have been paid $6.88 in the past year.
Dr Reddys Laboratories dividend payments have consistently grown over the past decade and have remained stable.
Find more data about Dr Reddys Laboratories dividend yield and history here.
Get analysis from other investors
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your RDY purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, place a limit order.
Hit the Open button and your broker will execute your order.
If you want additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Track your investment in RDY
Now that you own some RDY stock, you'll want to stay up-to-date on your new company.
Start a watchlist to keep tabs on your RDY stock.
RDY Feed
How to Buy Stock in Dr Reddys Laboratories
To summarize, here are the 6 steps for buying Dr Reddys Laboratories stock:
- Choose where to buy Dr Reddys Laboratories stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Dr Reddys Laboratories stock
- Make your RDY purchase
- Track your investment in RDY
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Dr Reddys Laboratories, add RDY to your watchlist below.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.